NCT02350231View on ClinicalTrials.gov

Progesterone Vaginal Pessary for Prevention of Preterm Twin Birth

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 1, 2014

Primary Completion Date

January 1, 2017

Study Completion Date

January 15, 2017

Conditions
Preterm Birth
Interventions
DRUG

The progesterone vaginal pessary

Those patients will receive progesterone vaginal pessary for prevention of preterm delivery in twins pregnancy

DRUG

Tonics group

Those patients will receive only tonics

All Listed Sponsors
collaborator

Sohag University

OTHER

lead

Assiut University

OTHER

NCT02350231 - Progesterone Vaginal Pessary for Prevention of Preterm Twin Birth | Biotech Hunter | Biotech Hunter